211 related articles for article (PubMed ID: 16804345)
21. Occult hepatitis B virus infection in chronic hemodialysis patients in Korea.
Gwak GY; Huh W; Lee DH; Min BH; Koh KC; Kim JJ; Oh HY
Hepatogastroenterology; 2008; 55(86-87):1721-4. PubMed ID: 19102377
[TBL] [Abstract][Full Text] [Related]
22. Predictors and kinetics of occult hepatitis B virus infection in HIV-infected persons.
Nebbia G; Garcia-Diaz A; Ayliffe U; Smith C; Dervisevic S; Johnson M; Gilson R; Tedder R; Geretti AM
J Med Virol; 2007 Oct; 79(10):1464-71. PubMed ID: 17705185
[TBL] [Abstract][Full Text] [Related]
23. Analysis of occult hepatitis B virus infection in liver tissue of HIV patients with chronic hepatitis C.
Raffa G; Maimone S; Cargnel A; Santantonio T; Antonucci G; Massari M; Schiavini M; Caccamo G; Pollicino T; Raimondo G
AIDS; 2007 Oct; 21(16):2171-5. PubMed ID: 18090043
[TBL] [Abstract][Full Text] [Related]
24. Occult HBV infection in cryptogenic liver cirrhosis in an area with high prevalence of HBV infection.
Chan HL; Tsang SW; Leung NW; Tse CH; Hui Y; Tam JS; Chan FK; Sung JJ
Am J Gastroenterol; 2002 May; 97(5):1211-5. PubMed ID: 12014730
[TBL] [Abstract][Full Text] [Related]
25. Molecular and serological aspects of HBsAg-negative hepatitis B virus infections in North America.
Hsia CC; Scudamore CH; Di Bisceglie AM; Tabor E
J Med Virol; 2003 May; 70(1):20-6. PubMed ID: 12629639
[TBL] [Abstract][Full Text] [Related]
26. Distribution of hepatitis B virus in the liver of chronic hepatitis C patients with occult hepatitis B virus infection.
Rodríguez-Iñigo E; Mariscal L; Bartolomé J; Castillo I; Navacerrada C; Ortiz-Movilla N; Pardo M; Carreño V
J Med Virol; 2003 Aug; 70(4):571-80. PubMed ID: 12794719
[TBL] [Abstract][Full Text] [Related]
27. Hepatitis B virus DNA in liver, serum, and peripheral blood mononuclear cells after the clearance of serum hepatitis B virus surface antigen.
Murakami Y; Minami M; Daimon Y; Okanoue T
J Med Virol; 2004 Feb; 72(2):203-14. PubMed ID: 14695661
[TBL] [Abstract][Full Text] [Related]
28. Frequent detection of hepatitis B virus DNA in hepatocellular carcinoma of patients with sustained virologic response for hepatitis C virus.
Tamori A; Hayashi T; Shinzaki M; Kobayashi S; Iwai S; Enomoto M; Morikawa H; Sakaguchi H; Shiomi S; Takemura S; Kubo S; Kawada N
J Med Virol; 2009 Jun; 81(6):1009-14. PubMed ID: 19382258
[TBL] [Abstract][Full Text] [Related]
29. Hepatitis B infection of the liver in chronic hepatitis C without detectable hepatitis B virus DNA in serum.
Mariscal LF; Rodríguez-Iñigo E; Bartolomé J; Castillo I; Ortiz-Movilla N; Navacerrada C; Pardo M; Pérez-Mota A; Graus J; Carreño V
J Med Virol; 2004 Jun; 73(2):177-86. PubMed ID: 15122790
[TBL] [Abstract][Full Text] [Related]
30. Evaluating the risk of hepatitis B reactivation in patients with haematological malignancies: is the serum hepatitis B virus profile reliable?
Ferraro D; Pizzillo P; Di Marco V; Vultaggio A; Iannitto E; Venezia G; Craxì A; Di Stefano R
Liver Int; 2009 Sep; 29(8):1171-7. PubMed ID: 19602139
[TBL] [Abstract][Full Text] [Related]
31. Prevalence of occult hepatitis B virus infection in a general adult population in Korea.
Song EY; Yun YM; Park MH; Seo DH
Intervirology; 2009; 52(2):57-62. PubMed ID: 19401629
[TBL] [Abstract][Full Text] [Related]
32. Molecular characterization of occult hepatitis B cases in Greek blood donors.
Katsoulidou A; Paraskevis D; Magiorkinis E; Moschidis Z; Haida C; Hatzitheodorou E; Varaklioti A; Karafoulidou A; Hatzitaki M; Kavallierou L; Mouzaki A; Andrioti E; Veneti C; Kaperoni A; Zervou E; Politis C; Hatzakis A
J Med Virol; 2009 May; 81(5):815-25. PubMed ID: 19319945
[TBL] [Abstract][Full Text] [Related]
33. Role of occult hepatitis B virus in chronic hepatitis C patients with flare of liver enzymes.
Selim HS; Abou-Donia HA; Taha HA; El Azab GI; Bakry AF
Eur J Intern Med; 2011 Apr; 22(2):187-90. PubMed ID: 21402251
[TBL] [Abstract][Full Text] [Related]
34. Hepatitis B virus and hepatitis C virus dual infection among patients with chronic liver disease.
Saravanan S; Velu V; Nandakumar S; Madhavan V; Shanmugasundaram U; Murugavel KG; Balakrishnan P; Kumarasamy N; Solomon S; Thyagarajan SP
J Microbiol Immunol Infect; 2009 Apr; 42(2):122-8. PubMed ID: 19597643
[TBL] [Abstract][Full Text] [Related]
35. [Can HBsAg levels guide to differentiate inactive HBsAg carriers from HBeAg negative chronic B hepatitis?].
Sayan M; Mutlu B; Erdoğan S; Meriç M; Willke A
Mikrobiyol Bul; 2007 Jan; 41(1):87-93. PubMed ID: 17427556
[TBL] [Abstract][Full Text] [Related]
36. Hepatitis gene chip in detecting HBV DNA, HCV RNA in serum and liver tissue samples of hepatitis patients.
Zhao W; Wan JM; Liu W; Liu QJ; Zhang L; Zhou ZX; Liu XJ; Zhang HR
Hepatobiliary Pancreat Dis Int; 2003 May; 2(2):234-41. PubMed ID: 14599976
[TBL] [Abstract][Full Text] [Related]
37. Low levels of awareness, vaccine coverage, and the need for boosters among health care workers in tertiary care hospitals in India.
Sukriti ; Pati NT; Sethi A; Agrawal K; Agrawal K; Kumar GT; Kumar M; Kaanan AT; Sarin SK
J Gastroenterol Hepatol; 2008 Nov; 23(11):1710-5. PubMed ID: 18761556
[TBL] [Abstract][Full Text] [Related]
38. Occult hepatitis B in renal transplant patients.
Peres AA; Dias EA; Chesky M; Alvares-da-Silva MR; Jobim LF; Gonçalves LF; Manfro RC
Transpl Infect Dis; 2005 Jun; 7(2):51-6. PubMed ID: 16150090
[TBL] [Abstract][Full Text] [Related]
39. Occult hepatitis B virus in liver tissue of individuals without hepatic disease.
Raimondo G; Navarra G; Mondello S; Costantino L; Colloredo G; Cucinotta E; Di Vita G; Scisca C; Squadrito G; Pollicino T
J Hepatol; 2008 May; 48(5):743-6. PubMed ID: 18314221
[TBL] [Abstract][Full Text] [Related]
40. Hepatitis B virus DNA in liver tissue and risk for hepatocarcinogenesis in patients with hepatitis C virus-related chronic liver disease. A prospective study.
Obika M; Shinji T; Fujioka S; Terada R; Ryuko H; Lwin AA; Shiraha H; Koide N
Intervirology; 2008; 51(1):59-68. PubMed ID: 18349544
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
